-
Mashup Score: 0ISCHEMIA Trials Land in NEJM While ACC.20 Airs Further Insights - 4 year(s) ago
If there was some skepticism alongside praise when the potentially seismic findings fell upon AHA 2020, will they meet more acceptance now that they are enshrined in a premier journal?
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1More than a third of heart docs report burnout. Here are some of the biggest contributing factors - 4 year(s) ago
Midcareer cardiologists were the most likely to report feeling burned out, according to a new survey presented at the American College of Cardiology’s annual scientific sessions, being held virtually together with the World Congress of Cardiology.
Source: FierceHealthcareCategories: General Medicine News, Latest HeadlinesTweet-
More than a third of cardiologists in U.S. report burnout. Survey results presented @ACCinTouch conference. #ACC20/#WCCardio https://t.co/Lx4mNx2xzV
-
-
Mashup Score: 0More Than 1 in 3 Cardiologists Burned Out, Many Ready to Bolt - 4 year(s) ago
‘These are not great signals, I think they’re shocking, quite frankly,’ one observer remarked.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
In the CIAO ancillary study of patients who were screened for the ISCHEMIA trials but were excluded because they had ischemia but no obstructive CAD, stress echocardiography results and angina frequency changed over time, researchers reported at the virtual American College of Cardiology Scientific Session. In addition, there was no correlation between change in ischemia and change in angina at 1
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 17Clinical implementation of clopidogrel pharmacogenetics: the Tailored Antiplatelet Therapy Following PCI (TAILOR-PCI) Trial - 4 year(s) ago
Current clinical guidelines do not recommend testing patients for the CYP2C19 genetic abnormality before prescribing clopidogrel.
Source: www.pcronline.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11Edoxaban noninferior to warfarin for thromboembolism, bleeding early after surgical valve implantation or repair - 4 year(s) ago
In patients who underwent surgical bioprosthetic valve implantation or repair, early postoperative anticoagulation with edoxaban was noninferior to warfarin for preventing thromboembolism and major bleeding during the first 3 months after the procedure, according to results of the ENAVLE trial presented at the virtual American College of Cardiology Scientific Session. “Our findings suggest
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4More than a third of heart docs report burnout. Here are some of the biggest contributing factors - 4 year(s) ago
Midcareer cardiologists were the most likely to report feeling burned out, according to a new survey presented at the American College of Cardiology’s annual scientific sessions, being held virtually together with the World Congress of Cardiology.
Source: FierceHealthcareCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7Patients: Their Journey, Their Lessons For Clinicians - American College of Cardiology - 4 year(s) ago
A patient – for the first time ever – will be the recipient of a Presidential Citation given at ACC.20/WCC. Richard J. Kovacs, MD, FACC, will present the award to his patient Michael C. Hiles, MSEE, PhD, during Convocation. “Dr. Hiles’ personal journey has made me a better cardiologist and is an important reminder…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Renal Denervation Shown Safe and Effective in Pivotal Trial - 4 year(s) ago
Primary results of the SPYRAL HTN-OFF MED trial showed ‘clinically meaningful’ blood pressure reductions at 3 months.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2VIDEO: TAVR Performs as Well as Surgery in Low-Risk Patients - 4 year(s) ago
A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line, Baylor Scott and White Health, Dallas Texas, chairman of the board of the BSW Health Research institute, Dallas, and co-principal investigator of the trial.
Source: DAICCategories: Cardiology News and Journals, Latest HeadlinesTweet
Never-before-seen details and further insight of the ISCHEMIA trial shared in NEJM. https://t.co/Q05h1peeKb #ACC20 #cardiotwitter